EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor
A compound or agent that combines with cyclooxygenases (EC 1.14.99.1) and thereby prevents its substrate-enzyme combination with arachidonic acid and the formation of icosanoids, prostaglandins, and thromboxanes.
|
|
photosensitizing agent
A chemical compound that can be excited by light of a specific wavelength and subsequently transfer energy to a chosen reactant. This is commonly molecular oxygen within a cancer tissue, which is converted to (highly rective) singlet state oxygen. This rapidly reacts with any nearby biomolecules, ultimately killing the cancer cells.
non-steroidal anti-inflammatory drug
An anti-inflammatory drug that is not a steroid. In addition to anti-inflammatory actions, non-steroidal anti-inflammatory drugs have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins.
|
|
2-(6-chloro-9H-carbazol-2-yl)propanoic acid
|
(±)-6-chloro-α-methylcarbazole-2-acetic acid
|
ChemIDplus
|
(+/-)-2-(3-chloro-9H-carbazol-7-yl)propanoic acid
|
ChEMBL
|
2-(6-Chloro-9H-carbazol-2-yl)-propionic acid
|
ChEMBL
|
6-chloro-α-methyl-9H-carbazole-2-acetic acid
|
ChEBI
|